2007
DOI: 10.1016/j.ejphar.2006.10.028
|View full text |Cite
|
Sign up to set email alerts
|

Antidepressant-induced undesirable weight gain: Prevention with rimonabant without interference with behavioral effectiveness

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
18
0

Year Published

2007
2007
2022
2022

Publication Types

Select...
4
4

Relationship

0
8

Authors

Journals

citations
Cited by 31 publications
(19 citation statements)
references
References 56 publications
1
18
0
Order By: Relevance
“…As shown by Nobrega and Coscina (1987), the effect of DMI decreasing body weight gain in rats seems to be due to a decreased food intake (Nobrega and Coscina 1987). This effect of DMI seems particularly important in rats, since with similar treatments, mice show initial decrease in body weight gain, but a significant increase after 2 months of treatment (Gobshtis et al 2007). Moreover, in human patients, treatment with DMI induces increase or not weight gain (Szarek and Brandt 1993).…”
Section: Discussionmentioning
confidence: 93%
“…As shown by Nobrega and Coscina (1987), the effect of DMI decreasing body weight gain in rats seems to be due to a decreased food intake (Nobrega and Coscina 1987). This effect of DMI seems particularly important in rats, since with similar treatments, mice show initial decrease in body weight gain, but a significant increase after 2 months of treatment (Gobshtis et al 2007). Moreover, in human patients, treatment with DMI induces increase or not weight gain (Szarek and Brandt 1993).…”
Section: Discussionmentioning
confidence: 93%
“…Very recently, another study with a similar rationale as ours explored the interaction between SR141716 and fluoxetine or desipramine, respectively, in the FST using female Sabra mice. 40 Yet, Gobshtis et al could neither demonstrate an interaction between SR141716 and the antidepressant drugs, nor an effect of SR141716 (5 mg/kg) alone. Future studies have to elucidate whether the independence of antidepressant actions from endocannabinoid signaling also holds true for male mice and other kinds or different doses of antidepressants.…”
Section: Discussionmentioning
confidence: 96%
“…40 To examine if the genetic knockout of CB1 leads to a different reaction or sensitivity to antidepressants in the FST, female CB1 þ / þ and CB1 À/À mice were treated with the NA reuptake inhibitor desipramine (Figure 4).…”
Section: Effects Of Sr141716 On Fst Behavior Are Specific For Cb1 Recmentioning
confidence: 99%
“…1) developed more than 35 years ago in Hebrew University and widely used for research in Israel. Sabra mice are commonly used in cannabinoid (Fride et al 1995;Fride et al 2003;Sumariwalla et al 2004;Avraham et al 2005;Gobshtis et al 2007; Kogan et al 2007), immunological (Berkowitz-Balshayi et al 1995;Castel et al 1997), antioxidant (Tirosh et al 1996;Dubnov et al 2000) anorexia (Bonne et al 2003), dermal (Touitou et al 2002), and other research fields (Shapira 1973). We recently used these animals to selectively breed a population of animals with prominent dominant and submissive features (Feder et al 2010).…”
Section: Introductionmentioning
confidence: 99%